| The effects of glutamine-supplemented parenteral nutrition in premature infants. | |
MedLine Citation:
|
PMID: 8788268 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Glutamine (GLN) is the primary fuel for rapidly dividing cells, yet it is not a constituent of parenteral nutritional formulas administered to newborns. The aims of this prospective, randomized, double-blind trial were (1) to confirm the safety of glutamine supplementation for premature infants and (2) to examine the effects of glutamine-supplemented parenteral nutrition on length of stay, days on total parenteral nutrition (TPN), days on the ventilator, and other clinical outcomes. METHODS: Premature infants received either standard or glutamine-supplemented TPN and were monitored throughout length of stay for various health and biochemical indices. The group was examined as a whole (n = 44; birth weight range: 530 to 1250 g) and in two weight subgroups, < 800 and > or = 800 g. RESULTS: Serum ammonia, blood urea nitrogen, and glutamate tended to be higher in the GLN groups, but the levels were well within normal limits. In the < 800-g cohort (n = 24), glutamine-supplemented infants required fewer days on TPN (13 vs 21 days, p = .02), had a shorter length of time to full feeds (8 vs 14 days, p = .03), and needed less time on the ventilator (38 vs 47 days, p = .04). There was a tendency toward a shorter length of stay in the NICU (73 vs 90 days, NS). These findings were not observed in the infants > or = 800 g (n = 20). CONCLUSIONS: Glutamine appears to be safe for use in premature infants and seems to be conditionally essential in premature infants with extremely low birth weights. Larger multicenter trials are needed to confirm these observations and further evaluate the efficacy of GLN in these high-risk premature infants. |
Authors:
|
J M Lacey; J B Crouch; K Benfell; S A Ringer; C K Wilmore; D Maguire; D W Wilmore |
Related Documents
:
|
25041388 - Tuning the developing brain to emotional body expressions. 3087658 - Biochemical markers in the assessment of protein-calorie malnutrition in premature neon... 8788268 - The effects of glutamine-supplemented parenteral nutrition in premature infants. 476208 - Assessment of ventilation-perfusion inequality by aadn2 in newborn infants. 23975948 - Cortical activation to action perception is associated with action production abilities... 18515298 - Prefrontal activation associated with social attachment: facial-emotion recognition in ... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: JPEN. Journal of parenteral and enteral nutrition Volume: 20 ISSN: 0148-6071 ISO Abbreviation: JPEN J Parenter Enteral Nutr Publication Date: 1996 Jan-Feb |
Date Detail:
|
Created Date: 1996-10-18 Completed Date: 1996-10-18 Revised Date: 2007-02-21 |
Medline Journal Info:
|
Nlm Unique ID: 7804134 Medline TA: JPEN J Parenter Enteral Nutr Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 74-80 Citation Subset: IM |
Affiliation:
|
Laboratory for Surgical Metabolism and Nutrition, Brigham and Women's Hospital, Boston, MA 02115, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Birth Weight Blood Urea Nitrogen Double-Blind Method Female Gestational Age Glutamic Acid / blood Glutamine / administration & dosage*, blood Humans Infant, Newborn Infant, Premature* Male Parenteral Nutrition, Total* Prospective Studies |
| Chemical | |
Reg. No./Substance:
|
56-85-9/Glutamine; 56-86-0/Glutamic Acid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Early enteral feeding in the pediatric intensive care unit.
Next Document: Fatal microvascular pulmonary emboli from precipitation of a total nutrient admixture solution.